Artios Pharma to Attend Upcoming Conferences in February and March 2021 18 February 2021 | Press release
Artios Pharma Announces the Start of First Clinical Study with the Dosing of its ATR Inhibitor, ART0380, to Patients 11 February 2021 | Press release
Artios Pharma Expands US Leadership Team with the Appointment of Abid Ansari as Chief Financial Officer 12 January 2021 | Press release
Merck KGaA, Darmstadt, Germany and Artios Pharma Announce a Global Strategic Collaboration on Novel DNA Damage Response Targets in Oncology 3 December 2020 | Press release
Artios Pharma Strengthens Clinical Development Team with Senior Appointments 10 February 2020 | Press release
Artios Pharma, MD Anderson and ShangPharma announce in-licensing agreement for DNA damage response inhibitor 6 November 2019 | Press release
Artios Pharma appoints Tania Dimitrova as Chief Business Officer and expands presence in the United States 24 September 2019 | Press release
Artios Pharma Announces Appointment of Dr. Ian Smith as Chief Medical Officer 1 April 2019 | Press release
Artios Pharma Announces Appointment of Professor Rajesh Chopra as Non-Executive Director 11 February 2019 | Press release
Artios Pharma Wins 2018 Lifestars EU Private Finance Raise of the Year Award 14 November 2018 | Press release